Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
Authors
Musa, AhmedKhalil, Eltahir
Hailu, Asrat
Olobo, Joseph
Balasegaram, Manica
Omollo, Raymond
Edwards, Tansy
Rashid, Juma
Mbui, Jane
Musa, Brima
Abuzaid, Abuzaid Abdalla
Ahmed, Osama
Fadlalla, Ahmed
El-Hassan, Ahmed
Mueller, Marius
Mucee, Geoffrey
Njoroge, Simon
Manduku, Veronica
Mutuma, Geoffrey
Apadet, Lilian
Lodenyo, Hudson
Mutea, Dedan
Kirigi, George
Yifru, Sisay
Mengistu, Getahun
Hurissa, Zewdu
Hailu, Workagegnehu
Weldegebreal, Teklu
Tafes, Hailemariam
Mekonnen, Yalemtsehay
Makonnen, Eyasu
Ndegwa, Serah
Sagaki, Patrick
Kimutai, Robert
Kesusu, Josephine
Owiti, Rhoda
Ellis, Sally
Wasunna, Monique
Affiliation
Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan; Addis Ababa University, Addis Ababa, Ethiopia; Makerere University, Kampala, Uganda; Médecins Sans Frontières-Holland, Amsterdam, The Netherlands; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya; Faculty of Medicine, Gedaref University, Gedaref, Sudan; Gondar University, Gondar, Ethiopia; Arba Minch Hospital, Regional Health Bureau of SNNPR State, Arba Minch, Ethiopia; University of Nairobi, Nairobi, Kenya; Amudat Hospital, Amudat, UgandaIssue Date
2012-06Submitted date
2011-10-11
Metadata
Show full item recordJournal
PLoS Neglected Tropical DiseasesAbstract
Alternative treatments for visceral leishmaniasis (VL) are required in East Africa. Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India.Publisher
Public Library of SciencePubMed ID
22724029Type
ArticleLanguage
enISSN
1935-2735ae974a485f413a2113503eed53cd6c53
10.1371/journal.pntd.0001674
Scopus Count
Collections
Related articles
- Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
- Authors: Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J, Leishmaniasis East Africa Platform (LEAP) group.
- Issue date: 2010 Oct 26
- Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
- Authors: Kimutai R, Musa AM, Njoroge S, Omollo R, Alves F, Hailu A, Khalil EA, Diro E, Soipei P, Musa B, Salman K, Ritmeijer K, Chappuis F, Rashid J, Mohammed R, Jameneh A, Makonnen E, Olobo J, Okello L, Sagaki P, Strub N, Ellis S, Alvar J, Balasegaram M, Alirol E, Wasunna M
- Issue date: 2017 Mar
- Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
- Authors: Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R
- Issue date: 2015 Dec
- Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.
- Authors: Melaku Y, Collin SM, Keus K, Gatluak F, Ritmeijer K, Davidson RN
- Issue date: 2007 Jul
- Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
- Authors: Rahman R, Goyal V, Haque R, Jamil K, Faiz A, Samad R, Ellis S, Balasegaram M, Boer MD, Rijal S, Strub-Wourgaft N, Alves F, Alvar J, Sharma B
- Issue date: 2017 May